These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 4822470)

  • 61. At the 75th anniversary of the bombings of Hiroshima and Nagasaki, the Radiation Effects Research Foundation continues studies of the atomic bomb survivors and their children.
    Samet JM; Niwa O
    Carcinogenesis; 2020 Nov; 41(11):1471-1472. PubMed ID: 33017841
    [No Abstract]   [Full Text] [Related]  

  • 62. Analysis of cancer mortality among atomic bomb survivors registered at Hiroshima University.
    Matsuura M; Hoshi M; Hayakawa N; Shimokata H; Ohtaki M; Ikeuchi M; Kasagi F
    Int J Radiat Biol; 1997 May; 71(5):603-11. PubMed ID: 9191905
    [TBL] [Abstract][Full Text] [Related]  

  • 63. A-bomb survivors: factors that may lead to a re-assessment of the radiation hazard.
    Stewart AM; Kneale GW
    Int J Epidemiol; 2000 Aug; 29(4):708-14. PubMed ID: 10922349
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Multiple myeloma among atomic bomb survivors in Hiroshima and Nagasaki, 1950-76: relationship to radiation dose absorbed by marrow.
    Ichimaru M; Ishimaru T; Mikami M; Matsunaga M
    J Natl Cancer Inst; 1982 Aug; 69(2):323-8. PubMed ID: 6955540
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Breast cancer incidence among atomic bomb survivors, Hiroshima and Nagasaki, 1950-69.
    McGregor H; Land CE; Choi K; Tokuoka S; Liu PI; Wakabayashi T; Beebe GW
    J Natl Cancer Inst; 1977 Sep; 59(3):799-811. PubMed ID: 894745
    [No Abstract]   [Full Text] [Related]  

  • 66. Late radiation responses in man: current evaluation from results from Hiroshima and Nagasaki.
    Schull WJ
    Adv Space Res; 1983; 3(8):231-9. PubMed ID: 11542750
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Aging in Hiroshima and Nagasaki atomic bomb survivors. Speculations based upon the age-specific mortality of persons with malignant neoplasms.
    Anderson RE; Key CR; Yamamoto T; Thorslund T
    Am J Pathol; 1974 Apr; 75(1):1-11. PubMed ID: 4825615
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Monitoring exposure to atomic bomb radiation by somatic mutation.
    Akiyama M; Kyoizumi S; Kusunoki Y; Hirai Y; Tanabe K; Cologne JB
    Environ Health Perspect; 1996 May; 104 Suppl 3(Suppl 3):493-6. PubMed ID: 8781371
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Solid cancer incidence in atomic bomb survivors exposed in utero or as young children.
    Preston DL; Cullings H; Suyama A; Funamoto S; Nishi N; Soda M; Mabuchi K; Kodama K; Kasagi F; Shore RE
    J Natl Cancer Inst; 2008 Mar; 100(6):428-36. PubMed ID: 18334707
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Leukaemia in Nagasaki atomic bomb survivors from 1945 through 1959.
    TOMONAGA M
    Bull World Health Organ; 1962; 26(5):619-31. PubMed ID: 13921808
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Perinatal loss and neurological abnormalities among children of the atomic bomb. Nagasaki and Hiroshima revisited, 1949 to 1989.
    Yamazaki JN; Schull WJ
    JAMA; 1990 Aug; 264(5):605-9. PubMed ID: 2366301
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Pathological and epidemiologic study of gastric cancer in atomic bomb survivors, Hiroshima and Nagasaki, 1959-77.
    Matsuura H; Yamamoto T; Sekine I; Ochi Y; Otake M
    J Radiat Res; 1984 Mar; 25(1):111-29. PubMed ID: 6330351
    [No Abstract]   [Full Text] [Related]  

  • 73. Salivary gland tumors among atomic bomb survivors, 1950-1987.
    Saku T; Hayashi Y; Takahara O; Matsuura H; Tokunaga M; Tokunaga M; Tokuoka S; Soda M; Mabuchi K; Land CE
    Cancer; 1997 Apr; 79(8):1465-75. PubMed ID: 9118025
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Stable chromosome aberrations among A-bomb survivors: an update.
    Stram DO; Sposto R; Preston D; Abrahamson S; Honda T; Awa AA
    Radiat Res; 1993 Oct; 136(1):29-36. PubMed ID: 8210335
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Adult stature in relation to childhood exposure to the atomic bombs of Hiroshima and Nagasaki.
    Belsky JL; Blot WJ
    Am J Public Health; 1975 May; 65(5):489-94. PubMed ID: 1130572
    [No Abstract]   [Full Text] [Related]  

  • 76. Delayed radiation effects in atomic-bomb survivors. Major observations by the Atomic Bomb Casualty Commission are evaluated.
    Miller RW
    Science; 1969 Oct; 166(3905):569-74. PubMed ID: 4898614
    [No Abstract]   [Full Text] [Related]  

  • 77. RELATIVE BIOLOGICAL EFFECTIVENESS OF NEUTRONS DERIVED FROM THE EXCESS RELATIVE RISK MODEL WITH THE ATOMIC BOMB SURVIVORS DATA MANAGED BY HIROSHIMA UNIVERSITY.
    Satoh K; Yasuda H; Kawakami H; Tashiro S
    Radiat Prot Dosimetry; 2018 Aug; 180(1-4):346-350. PubMed ID: 29036656
    [TBL] [Abstract][Full Text] [Related]  

  • 78. The LD50 associated with exposure to the atomic bombing of Hiroshima and Nagasaki.
    Fujita S; Kato H; Schull WJ
    J Radiat Res; 1991 Mar; 32 Suppl():154-61. PubMed ID: 1762100
    [TBL] [Abstract][Full Text] [Related]  

  • 79. The longest illness. Effects of nuclear war in children.
    Kappy MS
    Am J Dis Child; 1984 Mar; 138(3):293-8. PubMed ID: 6702776
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Studies of mortality of atomic bomb survivors. Report 13: Solid cancer and noncancer disease mortality: 1950-1997.
    Charles MW
    J Radiol Prot; 2003 Dec; 23(4):457-9. PubMed ID: 14750694
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.